South Korean officials say Kim Jong Un regains weight, fueling health woes
North Korean dictator Kim Jong Un has regained weight and his 5-foot 7-inch, 308-pound stature is exacerbating health problems, South Korean officials say.
Watch CBS News
North Korean dictator Kim Jong Un has regained weight and his 5-foot 7-inch, 308-pound stature is exacerbating health problems, South Korean officials say.
As weight loss drugs like Ozempic and Wegovy become more popular, obesity medicine specialists are concerned that not enough physicians have received specialized training to help patients navigate the medicine. Dr. Celine Gounder, CBS News medical contributor and editor-at-large for public health at KFF, has more on the situation.
Rising prices, insurance hurdles and a supply shortage can make access difficult for people who rely on drugs like Ozempic for diabetes and obesity, especially low-income patients. Renu Rayasam, senior correspondent with KFF Health News, joined CBS News to discuss the situation.
The obesity drug tirzepatide, or Zepbound, may help patients suffering from sleep apnea, according to a study by Eli Lilly. Gina Kolata, a medical reporter for the New York Times, joins CBS News with more details on the medical observation.
CBS News HealthWatch compiled a series of guides for preventative care and screenings to stay on top of your health at different ages throughout your life. Dr. Celine Gounder, a CBS News medical contributor and editor-at-large for public health at the Kaiser Family Foundation, breaks down the advice.
Nearly 1 in 5 kids has been diagnosed with childhood obesity. Low-income communities are hit even harder.
Dr. Celine Gounder, CBS News medical contributor and editor at large for Public Health at KFF, joins "CBS Mornings" to discuss a possible new approach to combating childhood obesity. In a new draft recommendation, the U.S. Preventative Task Force says doctors need to intervene as opposed to just screen for obesity and recommends children receive at least 26 hours of intensive counseling starting at age 6.
Doctors across the country are dealing with soaring demand for injectable weight-loss drugs, especially among people who are not clinically obese. Drugs like Ozempic and Wegovy have proved to be especially effective for weight loss, but some health experts are worried their increased use could potentially be harmful to certain patients. Dr. Shauna Levy, medical director of Tulane's Bariatric and Weight Loss Center, joined CBS News to discuss the medications.
The Food and Drug Administration has approved the diabetes drug Mounjaro, which will be marketed as a weight loss drug under the name Zepbound.
A new study shows the popular weight loss drug Wegovy can also reduce the risk of a heart attack or stroke by 20%. That's according to a not yet peer-reviewed clinical trial performed by drugmaker Novo Nordisk that studied more than 17,000 non-diabetic adults with heart disease who were obese or overweight. Cardiologist Dr. Ernst von Schwarz joins CBS News to discuss the significance of the findings.
A small but growing group of younger teens are trying more drastic treatments to lose large amounts of weight.
The New York City Council recently approved a bill that adds a person's weight to the list of characteristics protected from discrimination. Dr. Rebecca Puhl, deputy director of the Rudd Center for Food Policy and Health at the University of Connecticut, joined CBS News to talk about the legislation.
FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
American Marines and sailors gained weight, as well, a study shows. And there's no sign that the trend is ending, underscoring longstanding concerns about the readiness of America's fighting forces.
Struggling weight loss company looks to cash in on the craze for Ozempic and other drugs based on semaglutide.
The maker of semaglutide tells CBS News it has ramped up production "24-hours, seven days a week" to meet expected demand in new markets.
The report from the World Obesity Federation also predicts childhood obesity could more than double compared to 2020 levels.
Pre-canned cocktails, wine coolers and hard seltzers are increasingly popular, but the public health impacts of these drinks are largely unknown. Professor Matthew Rossheim from the University of North Texas joins "CBS News Weekender" host Catherine Herridge to discuss.
Children struggling with obesity should be evaluated and treated early and aggressively, according to new guidelines from the American Academy of Pediatrics. CBS News chief medical correspondent Dr. Jon LaPook shares more.
Lesley Stahl reports on how obesity is misunderstood, and the struggle to get new weight loss drugs to people who need them.
The longstanding practice of "watchful waiting," or delaying treatment to see whether children and teens outgrow or overcome obesity, "doesn't work," a leading researcher says.
The semaglutide injections have grown in popularity as a mechanism to help with weight loss for type 2 diabetes and obesity diagnoses.